Hematology-in-Focus Sessions

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall B

FANCONI ANEMIA

Chair: JA Bueren Roncero (Centro de investigaciones Energéticas, medioambientales y Tecnológicas (CIEMAT), Madrid, Spain)

• MOLECULAR DISSECTION OF THE FANCONI PATHWAY
  KJ Patel (MRC LMB, Cambridge, United Kingdom)
• BIOLOGY AND CLINICAL ASPECTS
  E Gluckman (Hopital Saint Louis, Paris, France)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall E

TET MUTATIONS IN MYELOID DISORDERS

Chair: R Skoda (University Hospital Basel, Basel, Switzerland)

• TET2 IN MDS, MPD, AML
  O Bernard (INSERM, Villejuif, France)
• DNA MODULATORY FUNCTION OF TET PROTEINS
  S Agarwal (Children's Hospital Boston, Boston, MA, USA)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall D

ALTERNATIVE DONOR TRANSPLANTS

Chair: C Craddock (Queen Elizabeth Hospital, Birmingham, Edgbaston, Birmingham, United Kingdom)

• DEVELOPING AN ALTERNATIVE DONOR ALGORYTHM
  V Rocha (Eurocord- Hopital Saint Louis, Paris, France)
• RESULTS IN ADULT CORD BLOOD TRANSPLANTATION
  G Sanz (Hospital Universitario La Fe, Valencia, Spain)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall F

INFECTIOUS AGENTS AND LYMPHOMA

Chair: C Montalban (Hospital Ramón y Cajal, Madrid, Spain)

• CHLAMYDIA INFECTION AND LYMPHOMA (BACTERIAL INFECTION)
  M Ponzoni (San Raffaele Scientific Institute, Milano, Italy)
• VIRAL AGENTS IN LYMPHOMA
  S Nakamura (Nagoya University Hospital, Nagoya, Japan)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall G

PROGRESS IN MYELOMA

Chair: G Morgan (The Instittue of Cancer Research & The Royal Marsden NHS Foundation Trust, London, United Kingdom)

• NEW GENES IN MYELOMA
  L Bergsagel (Mayo Clinic, Scottsdale, Arizona, USA)
• NEW TARGETED DRUGS IN MULTIPLE MYELOMA
  P Sonneveld (Erasmus MC and University, Rotterdam, The Netherlands)
  

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall M

MECHANISMS OF LYMPHOMAGENESIS

Chair: M Björkholm (Karolinska University Hospital and Institut, Stockholm, Sweden)

• TNFAIP3 (A20) IN NON-HODGKIN LYMPHOMA
  R Küppers (University of Duisburg-Essen, Medical School, Essen, Germany)
• NF-KB ACTIVATION IN DIFFUSE LARGE B CELL LYMPHOMA
  L Pasqualucci (Columbia University, New York, NY, USA)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall L

RED CELLS

Chair: C Beaumont (INSERM U773, Paris, France)

• RECENT DEVELOPMENTS IN MOLECULAR MECHANISMS OF IRON REGULATION
  C Camaschella (Vita-Salute University IRCCS San Raffaele, Milano, Italy)
• GATA-1 : A GLOBAL REGULATOR OF ERYTHROPOIESIS
  E Bresnick (University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall N

RIBOSOMAL DISORDERS

Chair: M von Lindern (Erasmus Medical Center, Rotterdam, The Netherlands)

• SCHWACHMANN DIAMOND
  J Rommens (The Hospital for Sick Children, Toronto, Canada)
• LINKING DEFECTIVE RIBOSOMES TO CANCER
  W Warren (University of Cambridge, Cambridge, United Kingdom)